Related Experiment Video
Updated: Oct 15, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Dominant expression of a novel splice variant of caspase-8 in human peripheral blood lymphocytes
T Horiuchi1, D Himeji, H Tsukamoto
1Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan. horiuchi@intmed1.med.kyushu-u.ac.jp
Abstract:
Caspase-8 is an apical and critical proteolytic enzyme in the cascade of apoptosis. As a result of alternative splicing, the generation of at least 7 isoforms of caspase-8 has been reported. The existence of multiple isoforms that lack the essential domains for apoptosis suggests the possible role of these isoforms on the regulation of apoptosis. Here we report a novel longer isoform of caspase-8 (caspase-8L) that was generated by alternative splicing of intron 8, thereby carrying a 136-bp insertion and frame shift of the transcript. The transcript encoded N-terminal two repeats of death effector domain (DED) of caspase-8, but lacking the C-terminal half of the proteolytic domain. Reverse transcriptase (RT)-polymerase chain reaction (PCR) analysis revealed the dominant expression of caspase-8L transcript compared to the intact form of caspase-8 in human peripheral blood lymphocyte (PBL) and T cells. In patients with systemic lupus erythematosus (SLE), imbalanced expression of caspase-8L transcript was identified. These results suggest the important role of caspase-8L in the modulation of apoptosis.
Insights
A novel caspase-8 isoform, caspase-8L, generated by alternative splicing, is predominantly expressed in human immune cells. Imbalanced caspase-8L expression was observed in systemic lupus erythematosus patients, suggesting its role in apoptosis regulation.
Area of Science:
- Molecular Biology
- Immunology
- Cell Biology
Background:
- Caspase-8 is a key enzyme in apoptosis.
- Alternative splicing generates multiple caspase-8 isoforms.
- Some isoforms may regulate apoptosis due to domain variations.
Purpose of the Study:
- To report a novel longer isoform of caspase-8, termed caspase-8L.
- To investigate the expression of caspase-8L in human immune cells.
- To explore the role of caspase-8L in systemic lupus erythematosus (SLE).
Main Methods:
- Alternative splicing analysis to identify caspase-8L.
- Reverse transcriptase-polymerase chain reaction (RT-PCR) for transcript expression analysis.
- Comparison of caspase-8L expression in healthy individuals and SLE patients.
Main Results:
- A novel caspase-8L isoform was identified, resulting from intron 8 splicing with a 136-bp insertion and frame shift.
- Caspase-8L transcript showed dominant expression over intact caspase-8 in human peripheral blood lymphocytes (PBL) and T cells.
- Imbalanced caspase-8L transcript expression was detected in patients with systemic lupus erythematosus (SLE).
Conclusions:
- Caspase-8L is a novel, alternatively spliced isoform of caspase-8.
- Caspase-8L is predominantly expressed in human PBL and T cells.
- The imbalanced expression of caspase-8L in SLE suggests its involvement in apoptosis modulation and potential disease relevance.
Related Concept Videos
RNA Splicing
Caspases
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

